Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rising Load Of Dermatology Diseases
3.2.2. Rise In Awareness Levels Of Disease Progression And Origin
3.3. Key Restraints
3.3.1. Severe Side Effects Of Certain Classes Of Therapeutic Drugs

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape

5. Market By Drug Class
5.1. Anti-Infectives
5.2. Corticosteroids
5.3. Anti-Acne
5.4. Calcineurin Inhibitors
5.5. Retinoids
5.6. Other Drug Classes

6. Market By Application
6.1. Alopecia
6.2. Herpes
6.3. Psoriasis
6.4. Rosacea
6.5. Atopic Dermatitis
6.6. Acne Vulgaris
6.7. Other Applications

7. Geographical Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada

8. Company Profiles
8.1. Abbvie Inc
8.2. Allergan Inc
8.3. Almiral
8.4. Amgen Inc
8.5. Bausch Health Companies Inc
8.6. Galderma
8.7. Glaxosmithkline Plc
8.8. Johnson & Johnson
8.9. Novartis Ag
8.10. Pfizer Inc
8.11. Agi Dermatics
8.12. Leo Pharma A/S
8.13. Merck Kgaa



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Dermatological Therapeutics Market, Growth Potential, By Drug Class, In 2019
Figure 6: North America Dermatological Therapeutics Market, By Anti-Infectives, 2019-2028 (In $ Billion)
Figure 7: North America Dermatological Therapeutics Market, By Corticosteroids, 2019-2028 (In $ Billion)
Figure 8: North America Dermatological Therapeutics Market, By Anti-Acne, 2019-2028 (In $ Billion)
Figure 9: North America Dermatological Therapeutics Market, By Calcineurin Inhibitors, 2019-2028 (In $ Billion)
Figure 10: North America Dermatological Therapeutics Market, By Retinoids, 2019-2028 (In $ Billion)
Figure 11: North America Dermatological Therapeutics Market, By Other Drug Classes, 2019-2028 (In $ Billion)
Figure 12: North America Dermatological Therapeutics Market, Growth Potential, By Application, In 2019
Figure 13: North America Dermatological Therapeutics Market, By Alopecia, 2019-2028 (In $ Billion)
Figure 14: North America Dermatological Therapeutics Market, By Herpes, 2019-2028 (In $ Billion)
Figure 15: North America Dermatological Therapeutics Market, By Psoriasis, 2019-2028 (In $ Billion)
Figure 16: North America Dermatological Therapeutics Market, By Rosacea, 2019-2028 (In $ Billion)
Figure 17: North America Dermatological Therapeutics Market, By Atopic Dermatitis, 2019-2028 (In $ Billion)
Figure 18: North America Dermatological Therapeutics Market, By Acne Vulgaris, 2019-2028 (In $ Billion)
Figure 19: North America Dermatological Therapeutics Market, By Other Applications, 2019-2028 (In $ Billion)
Figure 20: North America Dermatological Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 21: United States Dermatological Therapeutics Market, 2019-2028 (In $ Billion)
Figure 22: Canada Dermatological Therapeutics Market, 2019-2028 (In $ Billion)


List of Tables


TABLE 1: MARKET SNAPSHOT - DERMATOLOGICAL THERAPEUTICS
TABLE 2: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 3: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 4: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 5: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 6: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)